Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Chelsea Therapeutics International, Ltd. (NASDAQ: CHPT) breached their fiduciary duties in connection with the proposed sale of the Company to H. Ludbeck A/S. Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) weekly performance is 31.34%. On last trading day company shares ended up $6.58. Analysts mean target price for the company is $9.20. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) distance from 50-day simple moving average (SMA50) is 21.86%.
Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) is a development-stage biopharmaceutical company focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company is primarily focused on providing medicines to improve the health and quality of life of patients with minimal side effects. Ampio Pharmaceuticals Inc (NYSEMKT: AMPE) shares advanced 11.88% in last trading session and ended the day on $6.50. AMPE return on assets is -77.50%. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) quarterly performance is -21.21%.
STERIS Corporation (NYSE:STE) is a provider of infection prevention and surgical products and services, focused on healthcare, pharmaceutical and research. STERIS Corp. (NYSE:STE) updated its FY15 earnings guidance on Thursday. STERIS Corp (NYSE:STE) shares moved up 8.59% in last trading session and was closed at $51.73, while trading in range of $48.90 – $53.51. STERIS Corp (NYSE:STE) year to date (YTD) performance is 8.15%.
RXi Pharmaceuticals Corp (NASDAQ:RXII)announced results from the assessment of connective tissue growth factor (CTGF) protein levels following intravitreal injection, of RXI‑109 in the eyes of cynomolgus monkeys, as part of a dose-range finding study to build the Company’s ophthalmology franchise. RXi Pharmaceuticals Corp (NASDAQ:RXII) ended the last trading day at $3.19. Company weekly volatility is calculated as 13.81% and price to cash ratio as 2.98. RXi Pharmaceuticals Corp (NASDAQ:RXII) showed a positive weekly performance of 0.63%.
Leave a Reply